| 3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure–Activity Relationship Studies, and … M Majellaro, W Jespers, A Crespo, MJ Núñez, S Novio, J Azuaje, ... Journal of Medicinal Chemistry 64 (1), 458-480, 2020 | 23 | 2020 |
| Exploring Non-orthosteric Interactions with a Series of Potent and Selective A3 Antagonists D Miranda-Pastoriza, R Bernárdez, J Azuaje, R Prieto-Díaz, M Majellaro, ... ACS Medicinal Chemistry Letters 13 (2), 243-249, 2022 | 5 | 2022 |
| N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R) G Graziano, P Delre, F Carofiglio, J Brea, A Ligresti, M Kostrzewa, ... European Journal of Medicinal Chemistry 248, 115109, 2023 | 3 | 2023 |
| Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists C Val, C Rodríguez-García, R Prieto-Díaz, A Crespo, J Azuaje, ... Journal of Medicinal Chemistry 65 (3), 2091-2106, 2022 | 3 | 2022 |
| Pharmacological insights emerging from the characterization of a large collection of synthetic cannabinoid receptor agonists designer drugs C Gioé-Gallo, S Ortigueira, J Brea, I Raïch, J Azuaje, MR Paleo, ... Biomedicine & Pharmacotherapy 164, 114934, 2023 | 1 | 2023 |
| Study of A3 adenosine receptor interactions and identification of novel ant-/agonist using a specific fluorescent probe K Jecmenova, J Kotulova, S Gurska, M Majellaro, M Hajduch, E Sotelo, ... Cancer Research 83 (7_Supplement), 350-350, 2023 | | 2023 |
